MENS - Rasio utang marang kapitalisasi buku Jyong Biotech Limited

Jyong Biotech Ltd (MENS) develops unique, patent-protected plant-based medicines, which minimizes direct competition. The popularity of preventive therapy in Asia is driving expanded demand for men's health products. Meanwhile, the business's success relies on passing tests, with the current metric standing at 0.00. The price chart below illustrates the dynamics of an asset whose survival depends on its ability to outperform industry behemoths in complex research.

This ratio measures the proportion of debt relative to equity, allowing for an assessment of financial leverage and default risk at the current value of 0.00. Analyzing the total debt-to-book capital of Jyong Biotech Ltd (MENS) is critical for stress testing, as prolonged clinical drug trials require stable funding that cannot be secured solely through the automation of drug synthesis.